Investigator-initiated trial aims to provide proof-of-concept for bexmarilimab in overcoming acquired resistance to checkpoint inhibitors, a major challenge for most melanoma and lung cancer patients ...

Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sit on a metal counter. Inside these humble-looking jars is the core of Joan ...